#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA1679760	Functional	Antihyperlipidemic activity in po dosed Sprague-Dawley rat assessed as reduction of plasma triglyceride level after 6 hrs	Rattus norvegicus	1	ALA1671841	organism-based format	Scientific Literature
2.	ALA1679761	Functional	Antihyperlipidemic activity in po dosed Sprague-Dawley rat assessed as reduction of plasma free fatty acid level after 1 hr	Rattus norvegicus	1	ALA1671841	organism-based format	Scientific Literature
3.	ALA1680931	Functional	Antihyperlipidemic activity in po dosed Sprague-Dawley rat assessed as reduction of plasma triglyceride level after 1 hr	Rattus norvegicus	1	ALA1671841	organism-based format	Scientific Literature
4.	ALA1680932	Functional	Agonist activity at human GPR109b	Homo sapiens	3	ALA1671841	assay format	Scientific Literature
5.	ALA1680933	ADME	AUC (0 to 6 hrs) in rat at 10 mg/kg, po	Rattus norvegicus	2	ALA1671841	organism-based format	Scientific Literature
6.	ALA1680934	Functional	Agonist activity at cynomolgus monkey GPR109a	Macaca fascicularis	3	ALA1671841	assay format	Scientific Literature
7.	ALA1680935	Functional	Agonist activity at rat GPR109a	Rattus norvegicus	3	ALA1671841	assay format	Scientific Literature
8.	ALA1680936	Functional	Agonist activity at mouse GPR109a	Mus musculus	3	ALA1671841	assay format	Scientific Literature
9.	ALA1680937	Functional	Agonist activity at dog GPR109a	Canis lupus familiaris	3	ALA1671841	assay format	Scientific Literature
10.	ALA1680938	Functional	Antihyperlipidemic activity in Beagle dog assessed as reduction of plasma free fatty acid level at 1 mg/kg, po after 1 hr	Canis lupus familiaris	3	ALA1671841	organism-based format	Scientific Literature
11.	ALA1680940	Functional	Antihyperlipidemic activity in Sprague-Dawley rat assessed as reduction of plasma triglyceride level at 1 mg/kg, po after 1 hr	Rattus norvegicus	2	ALA1671841	organism-based format	Scientific Literature
12.	ALA1680942	Binding	Binding affinity to GPR109b		2	ALA1671841	single protein format	Scientific Literature
13.	ALA1680943	Functional	Antihyperlipidemic activity in Sprague-Dawley rat assessed as reduction of plasma free fatty acid level at 1 mg/kg, po after 1 hr	Rattus norvegicus	2	ALA1671841	organism-based format	Scientific Literature
14.	ALA1680944	Functional	Agonist activity at human recombinant GPR109a expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation	Homo sapiens	48	ALA1671841	cell-based format	Scientific Literature
15.	ALA1680945	Functional	Antihyperlipidemic activity in Sprague-Dawley rat assessed as reduction of plasma triglyceride level at 3 mg/kg, po after 8 hrs	Rattus norvegicus	1	ALA1671841	organism-based format	Scientific Literature
16.	ALA1680946	Functional	Antihyperlipidemic activity in Sprague-Dawley rat assessed as reduction of plasma triglyceride level at 3 mg/kg, po after 1 hr	Rattus norvegicus	1	ALA1671841	organism-based format	Scientific Literature
17.	ALA1680948	Functional	Antihyperlipidemic activity in Sprague-Dawley rat assessed as reduction of plasma free fatty acid level at 3 mg/kg, po after 1 hr	Rattus norvegicus	1	ALA1671841	organism-based format	Scientific Literature
18.	ALA1680949	Toxicity	Toxicity in Beagle dog assessed as changes in cutaneous blood flow at 3 mg/kg, po	Canis lupus familiaris	1	ALA1671841	organism-based format	Scientific Literature
19.	ALA1680950	Toxicity	Toxicity in Beagle dog assessed as changes in skin color at 3 mg/kg, po	Canis lupus familiaris	1	ALA1671841	organism-based format	Scientific Literature
20.	ALA1680951	Toxicity	Toxicity in Beagle dog assessed as changes in behavior activity at 3 mg/kg, po	Canis lupus familiaris	1	ALA1671841	organism-based format	Scientific Literature